Category: Cochrane

Improving opioid agonist care continuation, meta-analysis

handles

Improving opioid agonist care continuation remains to be a challenge for many community based addiction treatment organizations. Research into effective strategies has used both randomized and non-randomized designs. Is there any difference in treatment dropout between these different study types? (more…)

Can prescribers avoid contributing to opioid use disorder?

A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week follow-up with his family doctor for suture removal, he describes ongoing pain. Can prescribers avoid contributing to opioid use disorder? Is a renewal of opioid appropriate, potentially dangerous, or both? Read more

Can prescribers avoid contributing to opioid use disorder?

(more…)